Rostral anterior cingulate activity in major depressive disorder: State or trait marker of responsiveness to medication?

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 25, Issue 2, 2013, Pages 126-133

  Hunter, Aimee M ^a   Korb, Alexander S ^a   Cook, Ian A ^a   Leuchter, Andrew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ELECTROENCEPHALOGRAM; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; ROSTRAL ANTERIOR CINGULATE CORTEX; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; THETA RHYTHM; YOUNG ADULT;

EID: 84883303046     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11110330     Document Type: Article

References (39)

1. Mayberg HS, Brannan SK, Mahurin RK, et al: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8:1057-1061
2. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al: Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158:405-415
3. Saxena S, Brody AL, Ho ML, et al: Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003; 160:522-532
4. Mulert C, Juckel G, Brunnmeier M, et al: Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci 2007; 38:78-81
5. Korb AS, Hunter AM, Cook IA, et al: Rostral anterior cingulated cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol 2009; 120:1313-1319
6. Pizzagalli DA: Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011; 36:183-206
7. Korb AS, Hunter AM, Cook IA, et al: Rostral anterior cingulated cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res 2011; 192:188-194
8. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
9. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20):22-33, quiz 34-57
10. Cook IA, Leuchter AF, Morgan M, et al: Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002; 27:120-131
11. Hunter AM, Leuchter AF, Morgan ML, et al: Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 2006; 163:1426-1432
12. Mientus S, Gallinat J, Wuebben Y, et al: Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by low-resolution electromagnetic tomography (LORETA). Psychiatry Res 2002; 116:95-111
13. Bares M, Brunovsky M, Kopecek M, et al: Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment-resistant depressive disorder: a pilot study. J Psychiatr Res 2007; 41:319-325
14. Korb AS, Cook IA, Hunter AM, et al: Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr 2008; 21:138-146
15. Pascual-Marqui RD, Lehmann D, Koenig T, et al: Lowresolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 1999; 90:169-179
16. Hunter AM, Cook IA, Leuchter AF: Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol 2012; 22: 711-720.
17. Hunter AM, Leuchter AF, Morgan ML, et al: Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 2005; 30:792-799
18. Hunter AM, Ravikumar S, Cook IA, et al: Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatr Scand 2009; 119:266-273
19. Asada H, Fukuda Y, Tsunoda S, et al: Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 1999; 274:29-32
20. Ishii R, Shinosaki K, Ukai S, et al: Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 1999; 10:675-679
21. Pizzagalli DA, Oakes TR, Davidson RJ: Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects. Psychophysiology 2003; 40:939-949
22. Rutherford BR, Peterson BS, Roose SP: Patient expectancy of improvement may influence neuroimaging studies of Major Depression. Arch Gen Psychiatry 2011; http://archpsyc.ama-assn.org/cgi/eletters/67/11/1128
23. Wager TD, Rilling JK, Smith EE, et al: Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303:1162-1167
24. Ader R: The role of conditioning in pharmacotherapy, in The Placebo Effect. Edited by Harrington A. Cambridge, MA, Harvard University Press, 1997
25. Brody AL, Saxena S, Stoessel P, et al: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58:631-640
26. Shimizu E, Hashimoto K, Okamura N, et al: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54:70-75
27. Messa C, Colombo C, Moresco RM, et al: 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRIresponder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) 2003; 167:72-78
28. Parsey RV, Hastings RS, Oquendo MA, et al: Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006; 163:52-58
29. Mayberg HS: Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65:193-207
30. Cohen MX, Heller AS, Ranganath C: Functional connectivity with anterior cingulate and orbitofrontal cortices during decision-making. Brain Res Cogn Brain Res 2005; 23:61-70
31. Nieuwenhuys R, Voogd J, van Huijzen C: The Human Central Nervous System, 4th Edition. Berlin, Germany, Springer, 2007
32. Lane RD, Reiman EM, Axelrod B, et al: Neural correlates of levels of emotional awareness: evidence of an interaction between emotion and attention in the anterior cingulate cortex. J Cogn Neurosci 1998; 10:525-535
33. Etkin A, Egner T, Peraza DM, et al: Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 2006; 51:871-882
34. Eugène F, Joormann J, Cooney RE, et al: Neural correlates of inhibitory deficits in depression. Psychiatry Res 2010; 181:30-35
35. Morris JS, Smith KA, Cowen PJ, et al: Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage 1999; 10:163-172
36. Sargent PA, Kjaer KH, Bench CJ, et al: Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000; 57:174-180
37. Varnäs K, Halldin C, Hall H: Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 2004; 22:246-260
38. Goldapple K, Segal Z, Garson C, et al: Modulation of corticallimbic pathways in major depression: treatment-specific effects of cognitive-behavior therapy. Arch Gen Psychiatry 2004; 61:34-41
39. Chiesa A, Serretti A: Mindfulness-based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res 2011; 187:441-453